Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease Cardiomyopathies ESC Premium Access ESC Congress 2019

About the speaker

Photo

National & Kapodistrian University of Athens, Athens (Greece)

11 More presentations in this session

Presentation thumbnail
Doctor S. Tual-Chalot (Newcastle-Upon-Tyne, GB)
Presentation thumbnail
Doctor G. Vilahur (Barcelona, ES)
Presentation thumbnail
Professor G. De Luca (Messina, IT)
Presentation thumbnail
Miss I. Del Canto Serrano (Valencia, ES)
Presentation thumbnail
Doctor A. Kompa (Melbourne, AU)

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in

ESC 365 is supported by

ESC 365 is supported by